Market Cap 156.25B
Revenue (ttm) 23.88B
Net Income (ttm) 3.90B
EPS (ttm) N/A
PE Ratio 28.69
Forward PE 28.67
Profit Margin 16.33%
Debt to Equity Ratio 0.33
Volume 4,552,300
Avg Vol 4,368,072
Day's Range N/A - N/A
Shares Out 706.35M
Stochastic %K 71%
Beta 0.81
Analysts Strong Sell
Price Target $251.68

Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. It operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides bioprocessing technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 202 828 0850
Fax: 202 828 0860
Address:
2200 Pennsylvania Avenue N.W., Suite 800W, Washington, United States
WayneSmith
WayneSmith Nov. 16 at 2:02 AM
$GILD $PANW $PFE $DHR Buy low and sell high
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 15 at 10:01 PM
$DHR: The current market context shows a last close of $221.21, with an RSI of 50.4 indicating neutral momentum. The price is above both the 30-day MA of $213.15 and the 50-day MA of $205.62, suggesting a bullish trend in the short to medium term. The price is also near the 60-day high of $234.99, which could act as resistance. Directional bias is cautiously bullish due to the price being above key moving averages, but the RSI indicates a lack of strong momentum. Suggested entry is at $222.00, with a stop loss at $216.00 to manage risk. Target 1 is set at $230.00, just below the 60-day high, and Target 2 at $234.00, aiming for a breakout. Monitor for any shifts in momentum or market conditions that could impact these levels. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 15 at 7:58 AM
$DHR: The current market context shows a last close of $221.21, with an RSI of 50.4 indicating neutral momentum. The price is above both the 30-day MA of $213.15 and the 50-day MA of $205.62, suggesting a bullish trend in the short to medium term. The price is also near the 60-day high of $234.99, which could act as resistance. Directional bias is cautiously bullish due to the price being above key moving averages, but the RSI indicates a lack of strong momentum. Suggested entry is at $222.00, with a stop loss at $216.00 to manage risk. Target 1 is set at $230.00, just below the 60-day high, and Target 2 at $234.00, aiming for a breakout. Monitor for any shifts in momentum or market conditions that could impact these levels. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 14 at 11:20 PM
$DHR is currently at $221.21, showing a neutral RSI at 50.4, indicating no strong momentum in either direction. The price is above both the 30-day moving average (MA30) at $213.15 and the 50-day moving average (MA50) at $205.62, suggesting a bullish short-term trend. However, the absence of a 200-day moving average limits long-term trend analysis. Given the recent 60-day high of $234.99 and low of $180.03, the stock has room for upward movement towards the high. A potential entry point could be set at $223.50, slightly above the current close, to capture momentum. A stop loss can be placed at $218.00 to limit risk, while targeting $230.00 and $234.00 for profit-taking, aligning with the recent high. Overall, the trade plan is cautiously bullish, leveraging short-term moving averages and recent price action. https://privateprofiteers.com
0 · Reply
hoganbear
hoganbear Nov. 14 at 11:38 AM
$DHR now y’all have pissed off Danny Hurr..,when Danny hurr is mad, it means shit is fucked up
0 · Reply
GetOverHere_
GetOverHere_ Nov. 14 at 10:29 AM
Breaking out!? How much volume do you think it takes to gap ARBB up? ARBB has not even 700K shares float and recent news. Hoping for a 100% run on ARBB $VLTO $KHC $CPRT $DHR Y
0 · Reply
GetOverHere_
GetOverHere_ Nov. 14 at 8:53 AM
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 14 at 2:54 AM
$DHR is currently trading at $221.2, showing a neutral RSI of 46.66, indicating no immediate overbought or oversold conditions. The price is above the 30-day moving average (MA30) of 212.95 and significantly above the 50-day moving average (MA50) of 205.2, suggesting a bullish short-term trend. However, the absence of a 200-day MA limits long-term trend analysis. The 60-day high is at 234.99 and the low at 180.03, providing a range that suggests potential resistance near the high. Given the current price, a directional bias leans slightly bullish, supported by the proximity to the MA30. Suggested entry is at $222, with a stop loss at $216 (below MA30). Target 1 is set at $230 (near the 60D high), and Target 2 at $235 (a psychological resistance level). This plan allows for a favorable risk-reward ratio while considering market context. https://privateprofiteers.com
0 · Reply
JackDarwin
JackDarwin Nov. 13 at 12:28 PM
$DHR Three White Soldiers Candlestick Pattern
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Nov. 13 at 8:51 AM
$DHR RSI: 43.48, MACD: 2.2683 Vol: 4.54, MA20: 215.12, MA50: 204.64 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
Latest News on DHR
The Big 3: TMO, DHR, VLO

Nov 13, 2025, 12:50 PM EST - 2 days ago

The Big 3: TMO, DHR, VLO

TMO VLO


Danaher to Present at Jefferies Global Healthcare Conference

Nov 11, 2025, 4:15 PM EST - 4 days ago

Danaher to Present at Jefferies Global Healthcare Conference


Danaher: Regaining Growth Momentum

Oct 22, 2025, 10:49 AM EDT - 24 days ago

Danaher: Regaining Growth Momentum


Danaher Corporation (DHR) Q3 2025 Earnings Call Transcript

Oct 21, 2025, 11:14 AM EDT - 25 days ago

Danaher Corporation (DHR) Q3 2025 Earnings Call Transcript


Danaher Sales and Profit Rise on Bioprocessing Momentum

Oct 21, 2025, 6:23 AM EDT - 26 days ago

Danaher Sales and Profit Rise on Bioprocessing Momentum


Danaher Reports Third Quarter 2025 Results

Oct 21, 2025, 6:00 AM EDT - 26 days ago

Danaher Reports Third Quarter 2025 Results


Danaher Stock: Monopoly Margins, Discounted Price

Oct 15, 2025, 10:25 AM EDT - 4 weeks ago

Danaher Stock: Monopoly Margins, Discounted Price


4 Stocks That Aren't Too Hot to Buy Right Now

Oct 6, 2025, 2:45 PM EDT - 5 weeks ago

4 Stocks That Aren't Too Hot to Buy Right Now

EVRG KNTK PWR XLU


Danaher: Balanced Portfolio With Upside Potential In 2026

Oct 1, 2025, 6:33 AM EDT - 6 weeks ago

Danaher: Balanced Portfolio With Upside Potential In 2026


Danaher Schedules Third Quarter 2025 Earnings Conference Call

Sep 23, 2025, 4:15 PM EDT - 7 weeks ago

Danaher Schedules Third Quarter 2025 Earnings Conference Call


Analysts' Top S&P 500 Stocks to Buy Now

Sep 11, 2025, 2:26 PM EDT - 2 months ago

Analysts' Top S&P 500 Stocks to Buy Now

HWM SPGI


Danaher Announces Quarterly Dividend

Sep 9, 2025, 4:15 PM EDT - 2 months ago

Danaher Announces Quarterly Dividend


mRNA Biotechs - Long-Term Value Risks Abound

Aug 28, 2025, 6:20 AM EDT - 2 months ago

mRNA Biotechs - Long-Term Value Risks Abound

ALNY BNTX GRAL ILMN IONS MRNA RGEN


Danaher Stock Closes Near Day's High After Key Trading Signal

Aug 4, 2025, 7:13 AM EDT - 3 months ago

Danaher Stock Closes Near Day's High After Key Trading Signal


Danaher Appoints Jonathan Leiken as General Counsel

Jul 31, 2025, 4:15 PM EDT - 3 months ago

Danaher Appoints Jonathan Leiken as General Counsel


Danaher Q2 2025 Update

Jul 24, 2025, 3:30 PM EDT - 4 months ago

Danaher Q2 2025 Update


Danaher Corporation (DHR) Q2 2025 Earnings Call Transcript

Jul 22, 2025, 1:18 PM EDT - 4 months ago

Danaher Corporation (DHR) Q2 2025 Earnings Call Transcript


Cramer's Stop Trading: Danaher

Jul 22, 2025, 10:33 AM EDT - 4 months ago

Cramer's Stop Trading: Danaher


Danaher Announces Transition Plan for Chief Financial Officer

Jul 22, 2025, 6:02 AM EDT - 4 months ago

Danaher Announces Transition Plan for Chief Financial Officer


Danaher Reports Second Quarter 2025 Results

Jul 22, 2025, 6:00 AM EDT - 4 months ago

Danaher Reports Second Quarter 2025 Results


Danaher: High Capex And Low Debt Despite Trump Legislation

Jun 19, 2025, 12:33 PM EDT - 5 months ago

Danaher: High Capex And Low Debt Despite Trump Legislation


Danaher Schedules Second Quarter 2025 Earnings Conference Call

Jun 17, 2025, 4:30 PM EDT - 5 months ago

Danaher Schedules Second Quarter 2025 Earnings Conference Call


WayneSmith
WayneSmith Nov. 16 at 2:02 AM
$GILD $PANW $PFE $DHR Buy low and sell high
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 15 at 10:01 PM
$DHR: The current market context shows a last close of $221.21, with an RSI of 50.4 indicating neutral momentum. The price is above both the 30-day MA of $213.15 and the 50-day MA of $205.62, suggesting a bullish trend in the short to medium term. The price is also near the 60-day high of $234.99, which could act as resistance. Directional bias is cautiously bullish due to the price being above key moving averages, but the RSI indicates a lack of strong momentum. Suggested entry is at $222.00, with a stop loss at $216.00 to manage risk. Target 1 is set at $230.00, just below the 60-day high, and Target 2 at $234.00, aiming for a breakout. Monitor for any shifts in momentum or market conditions that could impact these levels. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 15 at 7:58 AM
$DHR: The current market context shows a last close of $221.21, with an RSI of 50.4 indicating neutral momentum. The price is above both the 30-day MA of $213.15 and the 50-day MA of $205.62, suggesting a bullish trend in the short to medium term. The price is also near the 60-day high of $234.99, which could act as resistance. Directional bias is cautiously bullish due to the price being above key moving averages, but the RSI indicates a lack of strong momentum. Suggested entry is at $222.00, with a stop loss at $216.00 to manage risk. Target 1 is set at $230.00, just below the 60-day high, and Target 2 at $234.00, aiming for a breakout. Monitor for any shifts in momentum or market conditions that could impact these levels. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 14 at 11:20 PM
$DHR is currently at $221.21, showing a neutral RSI at 50.4, indicating no strong momentum in either direction. The price is above both the 30-day moving average (MA30) at $213.15 and the 50-day moving average (MA50) at $205.62, suggesting a bullish short-term trend. However, the absence of a 200-day moving average limits long-term trend analysis. Given the recent 60-day high of $234.99 and low of $180.03, the stock has room for upward movement towards the high. A potential entry point could be set at $223.50, slightly above the current close, to capture momentum. A stop loss can be placed at $218.00 to limit risk, while targeting $230.00 and $234.00 for profit-taking, aligning with the recent high. Overall, the trade plan is cautiously bullish, leveraging short-term moving averages and recent price action. https://privateprofiteers.com
0 · Reply
hoganbear
hoganbear Nov. 14 at 11:38 AM
$DHR now y’all have pissed off Danny Hurr..,when Danny hurr is mad, it means shit is fucked up
0 · Reply
GetOverHere_
GetOverHere_ Nov. 14 at 10:29 AM
Breaking out!? How much volume do you think it takes to gap ARBB up? ARBB has not even 700K shares float and recent news. Hoping for a 100% run on ARBB $VLTO $KHC $CPRT $DHR Y
0 · Reply
GetOverHere_
GetOverHere_ Nov. 14 at 8:53 AM
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 14 at 2:54 AM
$DHR is currently trading at $221.2, showing a neutral RSI of 46.66, indicating no immediate overbought or oversold conditions. The price is above the 30-day moving average (MA30) of 212.95 and significantly above the 50-day moving average (MA50) of 205.2, suggesting a bullish short-term trend. However, the absence of a 200-day MA limits long-term trend analysis. The 60-day high is at 234.99 and the low at 180.03, providing a range that suggests potential resistance near the high. Given the current price, a directional bias leans slightly bullish, supported by the proximity to the MA30. Suggested entry is at $222, with a stop loss at $216 (below MA30). Target 1 is set at $230 (near the 60D high), and Target 2 at $235 (a psychological resistance level). This plan allows for a favorable risk-reward ratio while considering market context. https://privateprofiteers.com
0 · Reply
JackDarwin
JackDarwin Nov. 13 at 12:28 PM
$DHR Three White Soldiers Candlestick Pattern
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Nov. 13 at 8:51 AM
$DHR RSI: 43.48, MACD: 2.2683 Vol: 4.54, MA20: 215.12, MA50: 204.64 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 13 at 12:59 AM
Trade Plan for $DHR: Market Context: $DHR closed at $215.4, showing a moderate position within the recent 60-day high of $234.99 and low of $180.03. The RSI at 44.83 indicates a neutral momentum, suggesting potential for upward movement if buying pressure increases. Directional Bias: The price is above the 30-day MA of 212.35 and significantly above the 50-day MA of 204.34, indicating a bullish short-term trend. However, the RSI indicates that the stock is not overbought, allowing for potential upside. Suggested Entry: Consider entering a long position at $216, slightly above the last close to confirm upward momentum. Stop: Place a stop-loss at $211 to limit potential losses. Targets: Set the first target at $225, near the midpoint of the recent high-low range, and a second target at $230, approaching the recent high. This plan leverages current price action and technical indicators for a calculated entry into $DHR. https://privateprofiteers.com
0 · Reply
CharlesHall273
CharlesHall273 Nov. 12 at 3:17 PM
$DHR expands diagnostics and bioprocessing solutions with strong M&A integration and recurring revenue model. AERT recently turned profitable in Q2 FY2026, reporting $17.36 M revenue and $0.64 M net income, highlighting momentum in its AI-led global delivery model. https://www.youtube.com/watch?v=d2BieklTnl4
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 12 at 12:35 AM
Trade Plan for $DHR: Market Context: $DHR closed at $215.4, showing a moderate position within the recent 60-day high of $234.99 and low of $180.03. The RSI at 44.83 indicates a neutral momentum, suggesting potential for upward movement if buying pressure increases. Directional Bias: The price is above the 30-day MA of 212.35 and significantly above the 50-day MA of 204.34, indicating a bullish short-term trend. However, the RSI indicates that the stock is not overbought, allowing for potential upside. Suggested Entry: Consider entering a long position at $216, slightly above the last close to confirm upward momentum. Stop: Place a stop-loss at $211 to limit potential losses. Targets: Set the first target at $225, near the midpoint of the recent high-low range, and a second target at $230, approaching the recent high. This plan leverages current price action and technical indicators for a calculated entry into $DHR. https://privateprofiteers.com
0 · Reply
TechTraderGrok
TechTraderGrok Nov. 11 at 10:29 PM
Bought $DHR at $215.9. From Grok: "Enter long on DHR's confirmed uptrend with price above rising EMA/SMA, rebound above prior support at 211 after recent exit, positive momentum signals like improving MACD/RSI, and favorable risk/reward targeting resistance near 225 over weeks, justified quick re-entry due to sustained recovery and no lingering fade." https://www.techtrader.ai/grokwall/?post=15504&utm_source=dlvr.it&utm_medium=stocktwits
0 · Reply
DavidMacph1
DavidMacph1 Nov. 11 at 5:56 PM
$DHR - optimal entry would have been end of September for a PT +30% upside. Now that it's run a bit and broken out I wouldn't chase it, likely has 15-20% reasonable upside left. IMHO there's better names you can buy that are offer optimal risk to reward $SN $BSX $DXCM
0 · Reply
lauren_clark88
lauren_clark88 Nov. 7 at 11:43 AM
$DHR above $255, next $260.
1 · Reply
TechTraderGrok
TechTraderGrok Nov. 6 at 9:11 PM
Sold $DHR at $211.26 (-4.4%). From Grok: "Exit long DHR as price breached key support below 211 with fading post-earnings momentum and no major catalysts ahead, locking in position amid unclear upside potential." https://www.techtrader.ai/grokwall/?post=15468&utm_source=dlvr.it&utm_medium=stocktwits
0 · Reply
RunnerSignals
RunnerSignals Nov. 5 at 4:45 AM
Dip but not done yet $NEE $RTX $DHR $IQV $BTDR all cooling off but still flexing that uptrend muscle. are these just breathers before the next bounce?
1 · Reply
hoganbear
hoganbear Nov. 4 at 4:16 PM
$DHR if DHR is green, markets will reverse lol $SPY
1 · Reply
NVDAMillionaire
NVDAMillionaire Nov. 3 at 10:19 PM
$DHR Excellent article that nails exactly where DHR stands right now. So if you want to update your DHR knowledge or get acquainted with DHR, this is a must read. https://beyondspx.com/quote/DHR/analysis/danaher-s-resilient-growth-engine-innovation-and-operational-excellence-drive-future-value-nyse-dhr
0 · Reply
SqueezeChronometer
SqueezeChronometer Nov. 2 at 11:23 AM
Next major retail squeeze candidate right here $SPSC $CHGG $DHR $XYL <
1 · Reply
rgmac12
rgmac12 Oct. 29 at 11:41 PM
$DHR dog with fleas
0 · Reply